C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2002
11/07/2002	WO2002088396A2 Reagents and methods for automated in situ or microarray hybridization
11/07/2002	WO2002088309A2 Fusion genes associated with acute megakaryoblastic leukemias
11/07/2002	WO2002088184A1 A molecular marker
11/07/2002	WO2002088165A1 Elucidation of gene function
11/07/2002	WO2002088163A1 Antisense modulation of interferon gamma receptor 2 expression
11/07/2002	WO2002088160A1 Immobilization of oligonucleotides onto solid supports
11/07/2002	WO2002008237A3 Materials and methods for binding nucleic acids to surfaces
11/07/2002	WO2001045493A3 Transcription factor stress-related proteins and methods of use in plants
11/07/2002	WO2001020035A9 Methods and compositions for linear isothermal amplification of polynucleotide sequences
11/07/2002	US20020165389 Multiple-labelled oligonucleotides synthesized on solid-supports
11/07/2002	US20020165388 Contacting DNA or RNA with hydrogen peroxide and radical generating coordination complexes for a time and concentrations to produce aldehydes, reacting with an amine to produce a condensation product and labeling
11/07/2002	US20020165379 An isolated nucleic acid encoding a monomer of a calcium-activated potassium channel, and the monomer having molecular weight 40-80 kDa, unit conductance 2-6-pS, binding to antibodies generated against specific peptide sequence
11/07/2002	US20020165372 Nucleic acid labeling compounds
11/07/2002	US20020165199 Nucleosides for imaging and treatment applications
11/07/2002	US20020165189 Oligoribonucleotides and ribonucleases for cleaving RNA
11/07/2002	US20020165181 Oligonucleotides which contain region(s) of 2'-modified nucleosides connected by alternating phosphodiester and phosphorothioate linkages; use as antisense agents, assaying a nucleic acid; nuclease resistant
11/07/2002	US20020165143 Identification and isolation of novel DNA
11/07/2002	US20020165137 Diagnosing, treating, preventing and/or prognosing disorders related to these polypeptides
11/07/2002	US20020164756 Nucleotide sequences coding polypeptides for use in screening bactericides
11/07/2002	US20020164747 Gene cluster for ramoplanin biosynthesis
11/07/2002	US20020164737 Novel human kinase and polynucleotides encoding the same
11/07/2002	US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects
11/07/2002	US20020164685 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infectious diseases
11/07/2002	US20020164646 Nucleotide sequences coding polypeptide for use in the treatment and prevention of Inflammation, tumors, immunological, inflammatory bowel and crohn's disease
11/07/2002	US20020164626 Binding nucleic acids to carrier; obtain nucleic acid sample, dissolve in solvent, incubate with betaines, expose to carrier, recover bound carrier
11/07/2002	US20020164616 Crown ether derivatives
11/07/2002	US20020164605 Nanoparticles having oligonucleotides attached thereto and uses therefor
11/07/2002	US20020164601 Enzymatic polypeptide for use in the treatment of infections
11/07/2002	US20020164599 Electro-optical device and methods for hybridization and detection
11/07/2002	US20020164590 Solid support for use in the determination, classification and mapping of biopolymer sequences
11/07/2002	US20020164572 Human immunodeficiency virus (hiv); azt; pfa; drug resistant viral strains; reverse transcriptase inhibitors; lipophilic phosphonoacid/nucleoside conjugates, with exceptional anti-viral activity, for use against drug-resistant hiv strains
11/07/2002	US20020164353 Replication-defective adenovirus human type 5 recombinant as a vaccine carrier
11/07/2002	CA2445884A1 Elucidation of gene function
11/07/2002	CA2445847A1 A molecular marker
11/07/2002	CA2445423A1 Fusion genes associated with acute megakaryoblastic leukemias
11/06/2002	EP1254370A1 METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES
11/06/2002	EP1254272A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254266A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
11/06/2002	EP1254257A2 METHOD FOR GENERATION OF LONGER cDNA FRAGMENTS FROM SAGE TAGS FOR GENE IDENTIFICATION
11/06/2002	EP1254256A2 Novel nucleic acids and polypeptides
11/06/2002	EP1254248A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254242A1 17 human secreted proteins
11/06/2002	EP1254219A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254218A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254173A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254172A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254165A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254154A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254153A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254152A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254151A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254150A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254147A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1007718A4 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying
11/06/2002	EP0824598B1 METHOD FOR THE SPECIFIC COUPLING OF THE CAP OF THE EXTREMITY 5' OF A FRAGMENT mRNA AND PREPARATION OF mRNA AND COMPLETE cDNA
11/06/2002	EP0748382B1 Non-nucleotide containing enzymatic nucleic acid
11/06/2002	EP0623134B1 Metal complexes of water soluble texaphyrins
11/06/2002	CN1377974A Rice endosperm specific expression sequence label and constituted gene chip thereof
11/06/2002	CN1377968A Malignant malarial parasite new antigen candidate gene pfMAg
11/06/2002	CN1377967A Malignant malarial parasite dynein gene
11/06/2002	CN1377965A Human peptide transport protein 2 coding sequence, preparing method and use
11/06/2002	CN1377964A China bee and hornet hemolysis peptide precursor gene and coded polypeptide and preparing method
11/06/2002	CN1377963A China bee sedative peptide precursor gene and its coded polypeptide and preparing method
11/06/2002	CN1377962A Asia-africa hornet sedative peptide precursor gene and its coded polypeptide and preparing method
11/06/2002	CN1377891A Zinc finger protein from dendritic cell, its coding sequence and use
11/06/2002	CN1377886A Genosenoside biological synthesis relative gene
11/06/2002	CN1377885A Human signal conductive protein coding sequence, its preparing method and use
11/05/2002	US6476216 Preparation of phosphorothioate oligomers
11/05/2002	US6476215 Ink jet method of spotting a probe and manufacturing a probe array
11/05/2002	US6476213 Cloning and characterization of FLBA gene of H. pylori production of aflagellate
11/05/2002	US6476212 Polynucleotides and polypeptides derived from corn ear
11/05/2002	US6476205 2′ Modified oligonucleotides
11/05/2002	US6476000 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
11/05/2002	US6475997 Methods of stimulating phagocytosis
11/05/2002	US6475766 Human osteoclast-derived cathepsin
11/05/2002	US6475739 Determining genotype of human with preferential genetic disorder; obtain genomic sample of human, incubate with oligonucleotide primers, amplify nucleotide sequences, detect products, compare to control
11/05/2002	US6475487 Treatment of a patient by administering an antibody that inhibits cathepsin O
11/05/2002	US6475485 Two novel human cathepsin proteins
11/05/2002	CA2147124C Erythropoietin analogs
11/05/2002	CA2136831C Uses of nucleic acid analogues in the inhibition of nucleic acid amplification
11/05/2002	CA2091449C Cloning and sequencing of allergens of dermatophagoides (house dust mite)
11/03/2002	CA2384605A1 Granule-bound starch synthase
10/2002
10/31/2002	WO2002086441A2 Amplification and detection of mycoplasma pneumoniae
10/31/2002	WO2002086166A1 Method for analyzing nucleic acid reactions
10/31/2002	WO2002086165A1 Biological sample processing methods and compositions that include surfactants
10/31/2002	WO2002086160A1 Hybridization probes
10/31/2002	WO2002086088A2 Polymerases with charge-switch activity and methods of generating such polymerases
10/31/2002	WO2002085519A2 High capacity methods for separation, purification, concentration, immobilization and synthesis of compounds and applications based thereupon
10/31/2002	WO2002062197A3 Markers for disease susceptibility and targets for therapy
10/31/2002	WO2002055547A9 Sfrp and peptide motifs that interact with sfrp and methods of their use
10/31/2002	WO2002044416A3 Sulfonated diarylrhodamine dyes as fluorescent labels
10/31/2002	WO2002016023A3 Method and apparatus for in situ synthesis on a solid support
10/31/2002	WO2001075067A9 Novel nucleic acids and polypeptides
10/31/2002	WO2001049844A9 Compositions and methods for gene silencing
10/31/2002	US20020162136 For preventing and/or reducing fungal growth on a plant, plant tissue, seed or plant cell
10/31/2002	US20020161219 Non-enzymatic large scale synthesis of RNA
10/31/2002	US20020161213 Novel human kinases and polynucleotides encoding the same
10/31/2002	US20020161208 Useful for diagnosing, therapy, prophylaxis and/or prognosing disorders related to these novel polypeptides
10/31/2002	US20020161201 For use in cancer diagnosis and therapy
10/31/2002	US20020160972 Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers

1 ... 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 ... 899